Find latest Ovarian Cancer videos · 60+ videos

This video is featured in the 2024 ESMO Annual Meeting Insights Hub

ESMO 2024 Insights: Final OS From the ATALANTE/ENGOT-ov29 Trial Evaluating Atz vs. Placebo With Standard Cx + Bev in Ovarian Cancer Patients With Platinum-Sensitive Relapse

32 views
September 26, 2024
Comments 0
Login to view comments. Click here to Login